BIOCON
Back to Income Statement
|
BIOCON Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹16,927 Cr | ₹15,262 Cr | ₹14,756 Cr | ₹11,174 Cr | ₹8,184 Cr |
What is the latest Revenue of BIOCON ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹16,927 Cr |
| Mar2025 | ₹15,262 Cr |
| Mar2024 | ₹14,756 Cr |
| Mar2023 | ₹11,174 Cr |
| Mar2022 | ₹8,184 Cr |
How is Revenue of BIOCON Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹16,927 Cr | 10.91 | |
| Mar2025 | ₹15,262 Cr | 3.43 | |
| Mar2024 | ₹14,756 Cr | 32.05 | |
| Mar2023 | ₹11,174 Cr | 36.54 | |
| Mar2022 | ₹8,184 Cr | - | |
Compare Revenue of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹71,063.1 Cr | -1% | 4.9% | 8.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹473,509.0 Cr | 0.6% | 6% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,881.0 Cr | 1.2% | 10.5% | 7.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,832.0 Cr | -0.4% | 11% | 40.8% | Stock Analytics | |
| CIPLA | ₹113,894.0 Cr | -1.6% | -2.1% | -4.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,062.8 Cr | -4.6% | -14.8% | -8.4% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | -1% |
4.9% |
8.7% |
| SENSEX | -1.1% |
-0.2% |
-6.6% |
You may also like the below Video Courses